Positive news out of the United Kingdom with findings set to be published in the coming days demonstrating one dose of the Pfizer COVID-19 vaccine starts providing protection in as little as two weeks in younger adults, and three weeks in the elderly population. The data further demonstrates the vaccine is just as effective in people aged over 80-years as it is in people aged under 65-years.

One dose has shown to reduce symptomatic infection risk by 65% in younger adults and by 64% in people aged over 80 years, with protection rising to between 79% and 84% after two doses.

Scientists also note data regarding the AstraZeneca vaccine is showing similar levels of protection across all age groups.

The research is suggestive that people in Britain who have been vaccinated to date will have high levels of protection by the end of February, with admissions to intensive care expected to fall by up to a third by early March.

The Sun: Covid vaccine offers two-thirds protection in just ONE jab and will lead to lockdown escape

 

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。

分享这个